Short Communicaon Open access European Journal of Experimental Biology Corresponding author Greg Atkinson, Department of Genecs, University of Cambridge, United State. Email: atkinson. [email protected]. Citaon Atkinson G (2022) A Short Note on Trisomy 13: Patau’s Syndrome and It’s Diagnosis. Eur Exp Bio. Vol.12 No.1259 Copyright © Atkinson G. This is an open-access arcle distributed under the terms of the Creave Commons Aribuon Li- cense, which permits unrestricted use, distribuon, and reproducon in any medium, provided the original author and source are credited. © Under License of Creative Commons Attribution 4.0 License This arcle is available in: hps://www.primescholars.com/european-journal-of-experimental-biology Volume 12 • Issue 03 • 125 Received: 02- March -2022 Manuscript No: EJEBAU- 22-13198 Editor assigned: 04- March -2022 PreQC No: EJEBAU- 22-13198(PQ) Reviewed: 18- March -2022 QC No: EJEBAU- 22-13198 Revised: 23- March -2022 Manuscript No: EJEBAU- 22-13198(R) Published: 30- March -2022 DOI: 10.36648/2248 -9215.12.3.125 A Short Note on Trisomy 13: Patau’s Syndrome and It’s Diagnosis Greg Atkinson * Department of Genecs, University of Cambridge, United State INTRODUCTION Patau’s syndrome is a risky, intriguing hereditary condion brought about by an addional a duplicate of chromosome 13 in some or all cells of the body. Trisomy 13 is one more name for it. The qualies you gain from your folks are conveyed by 23 sets of chromosomes in every cell. Trisomy 13 causes patau disorder, and that implies that every cell in the body contains three duplicates of chromosome 13 rather than the ordinary two. Mosaic trisomy 13 depicts few circumstances in which only a poron of the body’s cells have an addional a duplicate. Clinical qualies, for example, holoprosencephaly, polydactyly, finger flexion, rocker-base feet, facial cleſting, brain tube ab- normalies, and heart issues are likewise normal. DESCRIPTION Patau disorder is described by the presence of physical birth irregularies and poor neurologic execuon upon entering the world. Patau disorder has a middle future of 7-10 days, and 90% of paents kick the bucket inside the main year of birth. Mosaicism and the seriousness of related anomalies are of- ten faulted for endurance. Patau’s condion (trisomy 13) is a remarkable problem that is connected to a high passing rate, an assortment of inherent peculiaries, and extreme physical and mental weakness. Numerous pregnancies impacted by the condion will end in unsuccessful labor, and most children brought into the world with the problem will just live for a cou- ple of days or weeks. Trisomy 13 infants can have an assort- ment of medical problems, and over 80% of them don’t live in excess of half a month. The individuals who in all actuality do so may encounter significant results, like breathing issues. Heart surrenders that are available upon entering the world. Since male embryos don’t get by ll birth, Patau seems to harm females more than guys. Patau disorder, similar to down condi- on, is connected to the mother’s old age. It can possibly hurt individuals of every single ethnic foundaon. Patau’s condion can cause an assortment of medical problems in children. Their development in the belly is for the most part limited, driving in low birth weight and serious heart anomalies in 8 out of 10 in- fants. The brain doesn’t necessarily separate into two secons. Holoprosencephaly is the clinical term for this condion. Pa- tau’s syndrome condion can cause an assortment of medical problems in infants. Their development in the belly is by and large limited, driving in low birth weight and serious heart ir- regularies in 8 out of 10 children. The mind doesn’t necessari- ly in every case paron into two secons. Holoprosencephaly is the clinical term for this condion. Patau’s disorder doesn’t have a conclusive treatment. Since it can’t be relieved, treat- ment is fundamentally centered on the child’s side effects [1-4]. CONCLUSION The clinics clerical’s staff will likely keep the newborn child as agreeable as conceivable while addionally guaranteeing that it can eat. Most of children brought into the world with this infecon don’t live to adulthood Treatment contrasts from one kid to another and centers around side effect help and com- plexies the execuves. Screening strategies like harmless Non-Invasive Prenatal Tesng (NIPT) and ultrasound assess- ments can idenfy pregnancies with a higher gamble of Triso- my 13. Chorionic villus inspecng (CVS) or amniocentesis can affirm the determinaon with more prominent than almost 100% precision before birth. The placenta (called a “chorionic villi test” or CVS) can be tried during the principal trimester of pregnancy, or the amnioc liquid (called an “amniocentesis”) can be tried during the second or third trimesters. ACKNOWLEDGMENT The author is grateful to the journal editor and the anonymous reviewers for their helpful comments and suggesons. CONFLICT OF INTEREST The author declared no potenal conflicts of interest for the research, authorship, and/or publicaon of this arcle.
A Short Note on Trisomy 13: Patau’s Syndrome and It’s Diagnosis
Oct 06, 2022
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Corresponding author Greg Atkinson, Department of Genetics, University of Cambridge, United State. Email: atkinson. [email protected].
Citation Atkinson G (2022) A Short Note on Trisomy 13: Patau’s Syndrome and It’s Diagnosis. Eur Exp Bio. Vol.12 No.1259
Copyright © Atkinson G. This is an open-access article distributed under the terms of the Creative Commons Attribution Li- cense, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
© Under License of Creative Commons Attribution 4.0 License This article is available in: https://www.primescholars.com/european-journal-of-experimental-biology Volume 12 • Issue 03 • 125
Received: 02- March -2022 Manuscript No: EJEBAU- 22-13198 Editor assigned: 04- March -2022 PreQC No: EJEBAU- 22-13198(PQ) Reviewed: 18- March -2022 QC No: EJEBAU- 22-13198 Revised: 23- March -2022 Manuscript No: EJEBAU- 22-13198(R) Published: 30- March -2022 DOI: 10.36648/2248 -9215.12.3.125
A Short Note on Trisomy 13: Patau’s Syndrome and It’s Diagnosis Greg Atkinson*
Department of Genetics, University of Cambridge, United State
INTRODUCTION Patau’s syndrome is a risky, intriguing hereditary condition brought about by an additional a duplicate of chromosome 13 in some or all cells of the body. Trisomy 13 is one more name for it. The qualities you gain from your folks are conveyed by 23 sets of chromosomes in every cell. Trisomy 13 causes patau disorder, and that implies that every cell in the body contains three duplicates of chromosome 13 rather than the ordinary two. Mosaic trisomy 13 depicts few circumstances in which only a portion of the body’s cells have an additional a duplicate. Clinical qualities, for example, holoprosencephaly, polydactyly, finger flexion, rocker-base feet, facial clefting, brain tube ab- normalities, and heart issues are likewise normal.
DESCRIPTION Patau disorder is described by the presence of physical birth irregularities and poor neurologic execution upon entering the world. Patau disorder has a middle future of 7-10 days, and 90% of patients kick the bucket inside the main year of birth. Mosaicism and the seriousness of related anomalies are of- ten faulted for endurance. Patau’s condition (trisomy 13) is a remarkable problem that is connected to a high passing rate, an assortment of inherent peculiarities, and extreme physical and mental weakness. Numerous pregnancies impacted by the condition will end in unsuccessful labor, and most children brought into the world with the problem will just live for a cou- ple of days or weeks. Trisomy 13 infants can have an assort- ment of medical problems, and over 80% of them don’t live in excess of half a month. The individuals who in all actuality do so may encounter significant results, like breathing issues. Heart surrenders that are available upon entering the world. Since male embryos don’t get by till birth, Patau seems to harm females more than guys. Patau disorder, similar to down condi- tion, is connected to the mother’s old age. It can possibly hurt individuals of every single ethnic foundation. Patau’s condition can cause an assortment of medical problems in children. Their
development in the belly is for the most part limited, driving in low birth weight and serious heart anomalies in 8 out of 10 in- fants. The brain doesn’t necessarily separate into two sections. Holoprosencephaly is the clinical term for this condition. Pa- tau’s syndrome condition can cause an assortment of medical problems in infants. Their development in the belly is by and large limited, driving in low birth weight and serious heart ir- regularities in 8 out of 10 children. The mind doesn’t necessari- ly in every case partition into two sections. Holoprosencephaly is the clinical term for this condition. Patau’s disorder doesn’t have a conclusive treatment. Since it can’t be relieved, treat- ment is fundamentally centered on the child’s side effects [1-4].
CONCLUSION The clinics clerical’s staff will likely keep the newborn child as agreeable as conceivable while additionally guaranteeing that it can eat. Most of children brought into the world with this infection don’t live to adulthood Treatment contrasts from one kid to another and centers around side effect help and com- plexities the executives. Screening strategies like harmless Non-Invasive Prenatal Testing (NIPT) and ultrasound assess- ments can identify pregnancies with a higher gamble of Triso- my 13. Chorionic villus inspecting (CVS) or amniocentesis can affirm the determination with more prominent than almost 100% precision before birth. The placenta (called a “chorionic villi test” or CVS) can be tried during the principal trimester of pregnancy, or the amniotic liquid (called an “amniocentesis”) can be tried during the second or third trimesters.
ACKNOWLEDGMENT The author is grateful to the journal editor and the anonymous reviewers for their helpful comments and suggestions.
CONFLICT OF INTEREST
The author declared no potential conflicts of interest for the research, authorship, and/or publication of this article.
Page 18 Atkinson G
Volume 12 • Issue 02 • 125
REFERENCES 1. M Pawelec, J Dugalik (2015) Medical and Ethical Consid-
erations Related to Viable Fetuses with Trisomy 13 in the 36th Week of Pregnancy–a Review of the Literature. Adv Clin Exp Med 24: 909-917.
2. C Wohlmuth, O Rittinger, T Fischer, D Wertaschnigg (2015) Cutaneous manifestations in trisomy 13 mosaicism: A rare case and review of the literature. Am J Med Genet A 167:
2294-2299. 3. CY Ting, NS Bhatia, JY Lim, CY Goh (2020) Further delin-
eation of CDC45-related Meier-Gorlin syndrome with cra- niosynostosis and review of literature. Eur J med genet 63: 103652.
4. IM Orioli, EE Castilla (2010) Epidemiology of holoprosen- cephaly: Prevalence and risk factors. Am J Med Genet 154: 13-21.
Citation Atkinson G (2022) A Short Note on Trisomy 13: Patau’s Syndrome and It’s Diagnosis. Eur Exp Bio. Vol.12 No.1259
Copyright © Atkinson G. This is an open-access article distributed under the terms of the Creative Commons Attribution Li- cense, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
© Under License of Creative Commons Attribution 4.0 License This article is available in: https://www.primescholars.com/european-journal-of-experimental-biology Volume 12 • Issue 03 • 125
Received: 02- March -2022 Manuscript No: EJEBAU- 22-13198 Editor assigned: 04- March -2022 PreQC No: EJEBAU- 22-13198(PQ) Reviewed: 18- March -2022 QC No: EJEBAU- 22-13198 Revised: 23- March -2022 Manuscript No: EJEBAU- 22-13198(R) Published: 30- March -2022 DOI: 10.36648/2248 -9215.12.3.125
A Short Note on Trisomy 13: Patau’s Syndrome and It’s Diagnosis Greg Atkinson*
Department of Genetics, University of Cambridge, United State
INTRODUCTION Patau’s syndrome is a risky, intriguing hereditary condition brought about by an additional a duplicate of chromosome 13 in some or all cells of the body. Trisomy 13 is one more name for it. The qualities you gain from your folks are conveyed by 23 sets of chromosomes in every cell. Trisomy 13 causes patau disorder, and that implies that every cell in the body contains three duplicates of chromosome 13 rather than the ordinary two. Mosaic trisomy 13 depicts few circumstances in which only a portion of the body’s cells have an additional a duplicate. Clinical qualities, for example, holoprosencephaly, polydactyly, finger flexion, rocker-base feet, facial clefting, brain tube ab- normalities, and heart issues are likewise normal.
DESCRIPTION Patau disorder is described by the presence of physical birth irregularities and poor neurologic execution upon entering the world. Patau disorder has a middle future of 7-10 days, and 90% of patients kick the bucket inside the main year of birth. Mosaicism and the seriousness of related anomalies are of- ten faulted for endurance. Patau’s condition (trisomy 13) is a remarkable problem that is connected to a high passing rate, an assortment of inherent peculiarities, and extreme physical and mental weakness. Numerous pregnancies impacted by the condition will end in unsuccessful labor, and most children brought into the world with the problem will just live for a cou- ple of days or weeks. Trisomy 13 infants can have an assort- ment of medical problems, and over 80% of them don’t live in excess of half a month. The individuals who in all actuality do so may encounter significant results, like breathing issues. Heart surrenders that are available upon entering the world. Since male embryos don’t get by till birth, Patau seems to harm females more than guys. Patau disorder, similar to down condi- tion, is connected to the mother’s old age. It can possibly hurt individuals of every single ethnic foundation. Patau’s condition can cause an assortment of medical problems in children. Their
development in the belly is for the most part limited, driving in low birth weight and serious heart anomalies in 8 out of 10 in- fants. The brain doesn’t necessarily separate into two sections. Holoprosencephaly is the clinical term for this condition. Pa- tau’s syndrome condition can cause an assortment of medical problems in infants. Their development in the belly is by and large limited, driving in low birth weight and serious heart ir- regularities in 8 out of 10 children. The mind doesn’t necessari- ly in every case partition into two sections. Holoprosencephaly is the clinical term for this condition. Patau’s disorder doesn’t have a conclusive treatment. Since it can’t be relieved, treat- ment is fundamentally centered on the child’s side effects [1-4].
CONCLUSION The clinics clerical’s staff will likely keep the newborn child as agreeable as conceivable while additionally guaranteeing that it can eat. Most of children brought into the world with this infection don’t live to adulthood Treatment contrasts from one kid to another and centers around side effect help and com- plexities the executives. Screening strategies like harmless Non-Invasive Prenatal Testing (NIPT) and ultrasound assess- ments can identify pregnancies with a higher gamble of Triso- my 13. Chorionic villus inspecting (CVS) or amniocentesis can affirm the determination with more prominent than almost 100% precision before birth. The placenta (called a “chorionic villi test” or CVS) can be tried during the principal trimester of pregnancy, or the amniotic liquid (called an “amniocentesis”) can be tried during the second or third trimesters.
ACKNOWLEDGMENT The author is grateful to the journal editor and the anonymous reviewers for their helpful comments and suggestions.
CONFLICT OF INTEREST
The author declared no potential conflicts of interest for the research, authorship, and/or publication of this article.
Page 18 Atkinson G
Volume 12 • Issue 02 • 125
REFERENCES 1. M Pawelec, J Dugalik (2015) Medical and Ethical Consid-
erations Related to Viable Fetuses with Trisomy 13 in the 36th Week of Pregnancy–a Review of the Literature. Adv Clin Exp Med 24: 909-917.
2. C Wohlmuth, O Rittinger, T Fischer, D Wertaschnigg (2015) Cutaneous manifestations in trisomy 13 mosaicism: A rare case and review of the literature. Am J Med Genet A 167:
2294-2299. 3. CY Ting, NS Bhatia, JY Lim, CY Goh (2020) Further delin-
eation of CDC45-related Meier-Gorlin syndrome with cra- niosynostosis and review of literature. Eur J med genet 63: 103652.
4. IM Orioli, EE Castilla (2010) Epidemiology of holoprosen- cephaly: Prevalence and risk factors. Am J Med Genet 154: 13-21.
Related Documents
